Learning to Trust genAI

Drug sponsors are asking 3 key questions:

• How can we apply AI in our operations to increase efficiency, speed, and quality?
• How can we leverage AI to reduce costs?
• Can we trust AI, and what are the risks associated?

Generative AI provides a once-in-a-generation opportunity to fundamentally move the needle on development speed, resource utilization, and quality.  Our generative AI solutions are based on learning from indication-specific development programs, regulatory guidance, and more – doing research for you.  Expertly written, our trial designs and synopses can be finalized in hours to days, not weeks to months.

Large pharma has already embraced AI in drug development, in areas of program execution, potentially increasing the imbalance of resources between large pharma and smaller organizations. Truly a game changer, we make state-of-the-art technology available to small/mid-size pharma and biotech companies, at a fraction of the historical cost for medical writing and consulting. 

Still skeptical? Trust in AI has been a primary source of delay in leveraging AI.  Our platform, waterwordsAI, undergoes rigorous testing for quality, accuracy, and rigor.  We also maintain a vital, “human-in-the-loop” process, keeping experts in full control. 

Curious? Schedule a 15-minute demo for a free trial – we know you’ll agree – waterworksAI can help you bring your drug to market faster, with fewer resources, and greater control.

Get in touch now to find out more! Sign up for a demo by clicking here!